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To the Editor:

We read with interest the publication by Hagström et al. reporting on pregnancy outcomes in patients with liver cirrhosis.[1](#hep41344-bib-0001){ref-type="ref"} These authors demonstrated in a large general population cohort that maternal liver cirrhosis is associated with an increased risk of (very) low birth weight (BW). This observation might have important implications for offspring health, as low BW is now an established risk factor for metabolic syndrome--related disease later in life.[2](#hep41344-bib-0002){ref-type="ref"} Thus, in our view, it would also be relevant and informative to follow up the children born to mothers with liver cirrhosis. The mechanism underlying the observed decreased BW is unclear. However, in patients with liver cirrhosis, circulating bile acids (BA) are commonly elevated. BA are increasingly recognized as endocrine mediators of a diverse range of (patho)physiological functions, including fertility.[3](#hep41344-bib-0003){ref-type="ref"}

Adding to the observations of Hagström et al., we investigated whether preconceptional alterations in maternal BA are associated with offspring BW. Serum BA were determined at ovum pickup in women undergoing modified natural‐cycle *in vitro* fertilization, a procedure close to normal physiology using minimal hormone dosages.[3](#hep41344-bib-0003){ref-type="ref"} The institutional review board waived approval, as only anonymized material/data were used, and patients did not object to use of waste material for research. The study was conducted in accordance with the 1975 Declaration of Helsinki. Sixty singleton deliveries, without clinical/laboratory indications for pre‐existing or gestational liver dysfunction, were included. Perinatal data have been published.[4](#hep41344-bib-0004){ref-type="ref"} A *z*‐score for BW after correction for gestational age, offspring gender, and parity was calculated (<http://www.perinatreg.nl/>). Serum levels of the primary BA chenodeoxycholic and cholic acid (Fig. [1](#hep41344-fig-0001){ref-type="fig"}) were significantly correlated with BW *z*‐scores (r = −0.288, *P* = 0.026 and r = −0.274, *P* = 0.034, respectively). After additional correction for maternal body mass index and smoking in a multivariate regression analysis, cholic and chenodeoxycholic acid were still significant predictors of BW (β = −477.9, *P* = 0.016 and β = −159.8, *P* = 0.009, respectively), while total and secondary BA remained unrelated.
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In summary, the present analysis demonstrates a significant relationship between higher primary BA in maternal serum at the time of conception and low fetal BW. These novel data extend the observations of Hagström et al. and suggest that even in individuals free of liver disease, maternal BA levels are associated with fetal growth.
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